Entertainment
View All
Arden Theatre Brings ‘Dear Evan Hansen’ to Philadelphia With Fresh, Modern Vision
PHILADELPHIA, PA — One of Broadway’s most talked-about musicals is set to take center stage in Old City, bringing a powerful story of connection, identity, and the impact of social …
Lifestyle
View All
Jennersville: Where the Music Still Echoes After the Crowd
By late afternoon, the traffic along Baltimore Pike slows just enough to notice what sits beyond it. Storefronts line the road in a familiar rhythm—parking lots, glass doors, people moving …
Pennsylvania
View All
Traffic Deaths Hit Record Low in PA, But Risks Remain
HARRISBURG, PA — Traffic fatalities in Pennsylvania dropped to their lowest level on record in 2025, even as officials warn that risky driving behaviors continue to pose serious dangers on …
National
View All
Social Media Scams Surge, Cost Americans $2.1B
WASHINGTON, D.C. — Nearly one in three scam victims who lost money in 2025 said the fraud began on social media, with total reported losses reaching $2.1 billion, according to …
Latest Articles
View All
Study Finds Most Top Financial Advisor Firms Use Generic Branding
PHILADELPHIA, PA — A review of the top 100 firms on the CNBC Financial Advisor 100 list found that most use similar, non-distinct language in their branding, according to an …
Healthcare Services Group Reports Q1 Revenue Increase, Reaffirms Outlook
BENSALEM, PA — Healthcare Services Group, Inc. (Nasdaq: HCSG) reported first-quarter revenue of $462.8 million for the period ended March 31, 2026, a 3.4% increase from the prior year, while …
Social Media Scams Surge, Cost Americans $2.1B
WASHINGTON, D.C. — Nearly one in three scam victims who lost money in 2025 said the fraud began on social media, with total reported losses reaching $2.1 billion, according to …
PECO CEO David Vahos to Transition, Mike Innocenzo Named Interim
PHILADELPHIA, PA — PECO President and CEO David Vahos will transition to a new role as special advisor to Exelon President and CEO Calvin Butler, with Exelon Chief Operating Officer …
Incyte to Present Phase 3 Tafasitamab Data at ASCO Meeting
WILMINGTON, DE — Incyte (Nasdaq: INCY) will present full results from a Phase 3 study of tafasitamab for first-line diffuse large B-cell lymphoma at the American Society of Clinical Oncology …